Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Development, validation and application of an inductively coupled plasma - mass spectrometry method to determine cobalt in metal-on-metal prosthesis patients using volumetric absorptive microsampling.

Capiau S, Bolea-Fernandez E, Balcaen L, Van Der Straeten C, Verstraete AG, Vanhaecke F, Stove CP.

Talanta. 2020 Feb 1;208:120055. doi: 10.1016/j.talanta.2019.06.055. Epub 2019 Jun 18.

PMID:
31816726
2.

Corrigendum to "Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study" [Journal of Critical Care 52 (2019) 75-79].

Dhaese SAM, Thooft ADJ, Farkas A, Lipman J, Verstraete AG, Stove V, Roberts JA, De Waele JJ.

J Crit Care. 2019 Nov 15. pii: S0883-9441(19)31431-5. doi: 10.1016/j.jcrc.2019.09.020. [Epub ahead of print] No abstract available.

PMID:
31740024
3.

Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion.

Dhaese SAM, Colin P, Willems H, Heffernan A, Gadeyne B, Van Vooren S, Depuydt P, Hoste E, Stove V, Verstraete AG, Lipman J, Roberts JA, De Waele JJ.

Int J Antimicrob Agents. 2019 Dec;54(6):741-749. doi: 10.1016/j.ijantimicag.2019.08.024. Epub 2019 Aug 31.

PMID:
31479741
4.

Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy.

Pelletti G, Verstraete AG, Reyns T, Barone R, Rossi F, Garagnani M, Pelotti S.

Forensic Sci Int. 2019 Sep;302:109914. doi: 10.1016/j.forsciint.2019.109914. Epub 2019 Aug 1.

PMID:
31419592
5.

Corrigendum to "Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients". [Int J Antimicrob Agents 51 (2018) 594-600].

Dhaese SAM, Roberts JA, Carlier M, Verstraete AG, Stove V, De Waele JJ.

Int J Antimicrob Agents. 2019 Sep;54(3):380. doi: 10.1016/j.ijantimicag.2019.07.022. Epub 2019 Aug 6. No abstract available.

PMID:
31399316
6.

Subtherapeutic piperacillin concentrations in neurocritical patients.

Damen C, Dhaese S, Verstraete AG, Stove V, De Waele JJ.

J Crit Care. 2019 Dec;54:48-51. doi: 10.1016/j.jcrc.2019.07.007. Epub 2019 Jul 10.

PMID:
31349159
7.

Corrigendum to 'Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients' [International Journal of Antimicrobial Agents 51 (2018) 594-600].

Dhaese SAM, Roberts JA, Carlier M, Verstraete AG, Stove V, DeWaele JJ.

Int J Antimicrob Agents. 2019 Aug;54(2):271. doi: 10.1016/j.ijantimicag.2019.07.007. Epub 2019 Jul 8. No abstract available.

PMID:
31296408
8.

Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study.

Dhaese SAM, Thooft ADJ, Farkas A, Lipman J, Verstraete AG, Stove V, Roberts JA, De Waele JJ.

J Crit Care. 2019 Aug;52:75-79. doi: 10.1016/j.jcrc.2019.04.013. Epub 2019 Apr 9. Erratum in: J Crit Care. 2019 Nov 15;:.

PMID:
30986758
9.

[Pediatric lumbar puncture: indications, execution and complications].

Héritier S, Torchin H, Verstraete A, De Suremain N, Leverger G, Carbajal R, Petit A.

Rev Prat. 2018 Apr;68(4):426-430. French.

PMID:
30869394
10.

Measuring antibiotics in exhaled air in critically ill, non-ventilated patients: A feasibility and proof of concept study.

Herregodts J, Van Vooren S, Deschuyteneer E, Dhaese SAM, Stove V, Verstraete AG, De Waele JJ.

J Crit Care. 2019 Jun;51:46-50. doi: 10.1016/j.jcrc.2019.01.025. Epub 2019 Jan 28.

PMID:
30745285
11.

Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance.

Colman S, Stove V, De Waele JJ, Verstraete AG.

Ther Drug Monit. 2019 Jun;41(3):325-330. doi: 10.1097/FTD.0000000000000602.

PMID:
30633089
12.

Development and validation of an ultra-high performance liquid chromatography - high resolution mass spectrometry method for the quantification of total and free teicoplanin in human plasma.

Deltombe O, Mertens T, Eloot S, Verstraete AG.

Clin Biochem. 2019 Mar;65:29-37. doi: 10.1016/j.clinbiochem.2018.12.010. Epub 2018 Dec 25.

PMID:
30592988
13.

Persistence of piperacillin concentrations after treatment discontinuation: in cauda venenum?

De Waele J, Van Eeckhout C, Vanhaelewyn P, Carlier M, Verstraete AG, Stove V.

Intensive Care Med. 2019 Jan;45(1):130-131. doi: 10.1007/s00134-018-5479-z. Epub 2018 Nov 27. No abstract available.

PMID:
30483837
14.

Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models.

Dhaese SAM, Farkas A, Colin P, Lipman J, Stove V, Verstraete AG, Roberts JA, De Waele JJ.

J Antimicrob Chemother. 2019 Feb 1;74(2):432-441. doi: 10.1093/jac/dky434.

PMID:
30376103
15.

[A rare cause of cryptorchidism, the persistence of müllerian ducts syndrome].

Lavergne O, Troisfontaines E, Verstraete A, Demarche M, Nicolas H.

Rev Med Liege. 2018 Jul;73(7-8):376-379. French.

16.

Assessment of the results of a three-year program for National Standardization and Quality Improvement of Medical Laboratories on Drug of Abuse Testing by the Ministry of Health in Turkey.

Küme T, Mercan F, Topsakal H, Karakukcu C, Şeneş M, Pınar A, Gürler M, Kalafat H, Ünal B, Verstraete AG, Hamurtekin Y, Aydınlı A, Şenol Y, Eğin ME, Cihan A, Kazancı EG, Gümüş E.

Drug Test Anal. 2019 Feb;11(2):215-222. doi: 10.1002/dta.2479. Epub 2018 Sep 17.

PMID:
30107637
17.

Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.

Verhoven SM, Groszek JJ, Fissell WH, Seegmiller A, Colby J, Patel P, Verstraete A, Shotwell M.

Clin Chim Acta. 2018 Jul;482:60-64. doi: 10.1016/j.cca.2018.03.021. Epub 2018 Mar 26.

18.

A pragmatic bottom-up approach to harmonize the units of clinical chemistry tests among Belgian clinical laboratories, focusing on immunoassays.

Demarteau M, Cammaert P, Vandevelde NM, Callewaert N, Coucke W, China B, Verstraete AG.

Clin Chem Lab Med. 2018 Dec 19;57(1):12-19. doi: 10.1515/cclm-2017-0824.

19.

Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.

Dhaese SAM, Roberts JA, Carlier M, Verstraete AG, Stove V, De Waele JJ.

Int J Antimicrob Agents. 2018 Apr;51(4):594-600. doi: 10.1016/j.ijantimicag.2017.12.015. Epub 2017 Dec 22. Erratum in: Int J Antimicrob Agents. 2019 Aug;54(2):271. Int J Antimicrob Agents. 2019 Sep;54(3):380.

PMID:
29277531
20.

Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.

Verstraete AG, Rigo-Bonnin R, Wallemacq P, Vogeser M, Schuetzenmeister A, Schmiedel C, Shipkova M.

Ther Drug Monit. 2018 Feb;40(1):59-68. doi: 10.1097/FTD.0000000000000474.

PMID:
29210975
21.

Proficiency Testing for Meropenem and Piperacillin Therapeutic Drug Monitoring: Preliminary Results From the Belgian Society on Infectiology and Clinical Microbiology Pharmacokinetic-Pharmacodynamic Working Group.

Carlier M, Athanasopoulos A, Borrey D, Colin P, Cotton F, Denooz R, Neels H, Spriet I, Ghys T, Verstraete AG, Stove V.

Ther Drug Monit. 2018 Feb;40(1):156-158. doi: 10.1097/FTD.0000000000000467. No abstract available.

PMID:
29140892
22.

Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patients.

Forier K, Van Heck V, Carlier M, Van Braeckel E, Van Daele S, De Baets F, Schelstraete P, Haerynck F, Stove V, Van Simaey L, Vaneechoutte M, Verstraete AG.

J Antimicrob Chemother. 2018 Jan 1;73(1):95-101. doi: 10.1093/jac/dkx331.

PMID:
29029070
23.

Dose optimization of piperacillin/tazobactam in critically ill children.

De Cock PAJG, van Dijkman SC, de Jaeger A, Willems J, Carlier M, Verstraete AG, Delanghe JR, Robays H, Vande Walle J, Della Pasqua OE, De Paepe P.

J Antimicrob Chemother. 2017 Jul 1;72(7):2002-2011. doi: 10.1093/jac/dkx093.

PMID:
28387840
24.

Hair cortisol in relation to job stress and depressive symptoms.

Janssens H, Clays E, Fiers T, Verstraete AG, de Bacquer D, Braeckman L.

Occup Med (Lond). 2017 Mar 1;67(2):114-120. doi: 10.1093/occmed/kqw114.

PMID:
27515972
25.

Δ(9)-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects following cannabis intake - A pilot study using illicit cannabis.

Coucke L, Massarini E, Ostijn Z, Beck O, Verstraete AG.

Clin Biochem. 2016 Sep;49(13-14):1072-7. doi: 10.1016/j.clinbiochem.2016.06.003. Epub 2016 Jun 8.

PMID:
27288550
26.

An Unusual Type of Kidney Stone.

De Koninck AS, Groen LA, Maes H, Verstraete AG, Stove V, Delanghe JR.

Clin Lab. 2016;62(1-2):235-9.

PMID:
27012055
27.

Disulfiram inhibition of cyanide formation after acetonitrile poisoning.

De Paepe P, Colin P, Depuydt P, Decavele AS, De Smet J, Boussery K, Stove C, Benoit D, Verstraete A, Van Bocxlaer J, Buylaert W.

Clin Toxicol (Phila). 2016;54(1):56-60. doi: 10.3109/15563650.2015.1101770. Epub 2015 Dec 1.

PMID:
26623950
28.

Influence of Sampling Procedure on Codeine Concentrations in Oral Fluid.

Coucke LD, De Smet L, Verstraete AG.

J Anal Toxicol. 2016 Mar;40(2):148-52. doi: 10.1093/jat/bkv123. Epub 2015 Oct 29.

PMID:
26514755
29.

Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children.

De Cock PA, Standing JF, Barker CI, de Jaeger A, Dhont E, Carlier M, Verstraete AG, Delanghe JR, Robays H, De Paepe P.

Antimicrob Agents Chemother. 2015 Nov;59(11):7027-35. doi: 10.1128/AAC.01368-15. Epub 2015 Sep 8.

30.

Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.

Gjerde H, Langel K, Favretto D, Verstraete AG.

Forensic Sci Int. 2015 Nov;256:42-5. doi: 10.1016/j.forsciint.2015.06.027. Epub 2015 Jul 10.

PMID:
26295911
31.

Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review.

Carlier M, Stove V, Wallis SC, De Waele JJ, Verstraete AG, Lipman J, Roberts JA.

Int J Antimicrob Agents. 2015 Oct;46(4):367-75. doi: 10.1016/j.ijantimicag.2015.06.016. Epub 2015 Jul 29. Review.

PMID:
26271599
32.

A comparative study of screening instruments and biomarkers for the detection of cannabis use.

Meersseman P, Vanhoutte S, Van Damme J, Maes L, Lemmens G, Heylens G, Verstraete AG.

Subst Abus. 2016;37(1):176-80. doi: 10.1080/08897077.2015.1037947. Epub 2015 Jul 9.

PMID:
26158599
33.

Stability of amoxicillin and amoxicillin/clavulanic acid reconstituted in isotonic saline.

Carlier M, Verstraete AG, De Waele JJ, Stove V.

J Chemother. 2017 Feb;29(1):54-56. doi: 10.1179/1973947815Y.0000000052. Epub 2016 Jul 22. No abstract available.

PMID:
26032969
34.

A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients.

Carlier M, Roberts JA, Stove V, Verstraete AG, Lipman J, De Waele JJ.

Antimicrob Agents Chemother. 2015 Aug;59(8):4689-94. doi: 10.1128/AAC.00409-15. Epub 2015 May 26.

35.

Application of the characteristic function to evaluate and compare analytical variability in an external quality assessment scheme for serum ethanol.

Coucke W, Charlier C, Lambert W, Martens F, Neels H, Tytgat J, Van de Walle P, Vanescote A, Wallemacq P, Wille S, Verstraete AG.

Clin Chem. 2015 Jul;61(7):948-54. doi: 10.1373/clinchem.2015.240176. Epub 2015 May 19.

36.

[Drug use and driving].

Lemaire-Hurtel AS, Goullé JP, Alvarez JC, Mura P, Verstraete AG.

Presse Med. 2015 Oct;44(10):1055-63. doi: 10.1016/j.lpm.2015.03.007. Epub 2015 May 5. Review. French.

PMID:
25956300
37.

What are the most important tasks of tutors during the tutorials in hybrid problem-based learning curricula?

Boelens R, De Wever B, Rosseel Y, Verstraete AG, Derese A.

BMC Med Educ. 2015 May 6;15:84. doi: 10.1186/s12909-015-0368-4.

38.

How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme.

Delattre IK, Van de Walle P, Van Campenhout C, Neels H, Verstraete AG, Wallemacq P.

Clin Biochem. 2015 Jun;48(9):617-21. doi: 10.1016/j.clinbiochem.2015.03.009. Epub 2015 Mar 25.

PMID:
25818475
39.

Roadside drug testing: comparison of two legal approaches in Belgium.

Van der Linden T, Wille SM, Ramírez-Fernandez M, Verstraete AG, Samyn N.

Forensic Sci Int. 2015 Apr;249:148-55. doi: 10.1016/j.forsciint.2015.01.034. Epub 2015 Feb 4.

PMID:
25700110
40.

Erratum.

Vanstechelman S, Verstraete A.

J Anal Toxicol. 2015 Mar;39(2):162. doi: 10.1093/jat/bku179. No abstract available.

PMID:
25670842
41.

Ultrafast quantification of β-lactam antibiotics in human plasma using UPLC-MS/MS.

Carlier M, Stove V, De Waele JJ, Verstraete AG.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jan 26;978-979:89-94. doi: 10.1016/j.jchromb.2014.11.034. Epub 2014 Dec 8.

PMID:
25531875
42.

Unexpected overestimation of methotrexate plasma concentrations: importance of the assay implementation and its validation.

Godefroid M, Verstraete AG, Stove V.

Ther Drug Monit. 2015 Jun;37(3):417-8. doi: 10.1097/FTD.0000000000000150. No abstract available.

PMID:
25384120
43.

Exploration of the pre-analytical stability of β-lactam antibiotics in plasma and blood--implications for therapeutic drug monitoring and pharmacokinetic studies.

Carlier M, De Waele JJ, Verstraete AG, Stove V.

Clin Chem Lab Med. 2015 Aug;53(9):e227-30. doi: 10.1515/cclm-2014-0833. No abstract available.

PMID:
25381954
44.

Therapeutic drug monitoring of voriconazole: validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography.

Cattoir L, Fauvarque G, Degandt S, Ghys T, Verstraete AG, Stove V.

Clin Chem Lab Med. 2015 Apr;53(5):e135-9. doi: 10.1515/cclm-2014-0774. No abstract available.

PMID:
25336499
45.

Stability of generic brands of meropenem reconstituted in isotonic saline.

Carlier M, Stove V, Verstraete AG, De Waele JJ.

Minerva Anestesiol. 2015 Mar;81(3):283-7. Epub 2014 Sep 15.

46.

Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.

Stove V, Coene L, Carlier M, De Waele JJ, Fiers T, Verstraete AG.

Ther Drug Monit. 2015 Apr;37(2):180-7. doi: 10.1097/FTD.0000000000000122. Erratum in: Ther Drug Monit. 2015 Aug;37(4):554.

PMID:
25072945
47.

Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures.

Carlier M, Noë M, Roberts JA, Stove V, Verstraete AG, Lipman J, De Waele JJ.

J Antimicrob Chemother. 2014 Oct;69(10):2797-803. doi: 10.1093/jac/dku195. Epub 2014 Jun 10.

PMID:
24917580
48.

Investigation of urinary excretion of hydroxyethyl starch and dextran by uhplc-hrms in different acquisition modes.

Esposito S, Deventer K, Giron AJ, Roels K, Herregods L, Verstraete A, Van Eenoo P.

Biol Sport. 2014 Jun;31(2):95-104. doi: 10.5604/20831862.1096045. Epub 2014 Apr 5.

49.

Multi-center analytical evaluation of a novel automated tacrolimus immunoassay.

Shipkova M, Vogeser M, Ramos PA, Verstraete AG, Orth M, Schneider C, Wallemacq P.

Clin Biochem. 2014 Aug;47(12):1069-77. doi: 10.1016/j.clinbiochem.2014.03.023. Epub 2014 Apr 12.

50.

Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course.

Carlier M, Carrette S, Stove V, Verstraete AG, De Waele JJ.

Int J Antimicrob Agents. 2014 May;43(5):470-3. doi: 10.1016/j.ijantimicag.2014.01.028. Epub 2014 Mar 15.

PMID:
24685990

Supplemental Content

Loading ...
Support Center